Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 23% ± 8% | |
ciliated cell | 5 studies | 27% ± 8% | |
astrocyte | 5 studies | 25% ± 8% | |
B cell | 4 studies | 22% ± 4% | |
epithelial cell | 4 studies | 39% ± 10% | |
glutamatergic neuron | 4 studies | 35% ± 12% | |
macrophage | 4 studies | 20% ± 5% | |
microglial cell | 3 studies | 23% ± 2% | |
memory B cell | 3 studies | 17% ± 1% | |
lymphocyte | 3 studies | 23% ± 3% | |
basal cell | 3 studies | 28% ± 13% | |
GABAergic neuron | 3 studies | 33% ± 4% | |
pericyte | 3 studies | 18% ± 4% | |
transit amplifying cell | 3 studies | 31% ± 19% | |
neuron | 3 studies | 21% ± 4% | |
oligodendrocyte | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4372.76 | 1445 / 1445 | 100% | 26.02 | 183 / 183 |
ovary | 100% | 5528.84 | 180 / 180 | 100% | 24.84 | 430 / 430 |
lung | 100% | 4238.07 | 578 / 578 | 100% | 22.22 | 1154 / 1155 |
breast | 100% | 5125.20 | 459 / 459 | 100% | 31.32 | 1117 / 1118 |
prostate | 100% | 4310.21 | 245 / 245 | 100% | 20.76 | 501 / 502 |
thymus | 100% | 5423.20 | 653 / 653 | 100% | 25.95 | 603 / 605 |
stomach | 100% | 3341.77 | 359 / 359 | 100% | 17.60 | 285 / 286 |
intestine | 100% | 4745.35 | 966 / 966 | 100% | 17.34 | 525 / 527 |
bladder | 100% | 5264.76 | 21 / 21 | 100% | 16.69 | 502 / 504 |
uterus | 100% | 5774.01 | 170 / 170 | 100% | 21.88 | 457 / 459 |
brain | 99% | 2372.34 | 2613 / 2642 | 100% | 20.69 | 705 / 705 |
skin | 100% | 5264.36 | 1809 / 1809 | 98% | 22.32 | 464 / 472 |
kidney | 100% | 2737.63 | 89 / 89 | 98% | 15.89 | 880 / 901 |
pancreas | 98% | 1960.35 | 322 / 328 | 99% | 17.10 | 176 / 178 |
adrenal gland | 100% | 3442.94 | 258 / 258 | 94% | 13.34 | 216 / 230 |
liver | 100% | 1723.05 | 225 / 226 | 88% | 9.17 | 356 / 406 |
adipose | 100% | 4678.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.43 | 29 / 29 |
muscle | 100% | 2475.88 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4434.68 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.14 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.04 | 1 / 1 |
blood vessel | 100% | 4976.65 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 2022.09 | 832 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 15.42 | 77 / 80 |
peripheral blood | 95% | 2991.56 | 882 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002244 | Biological process | hematopoietic progenitor cell differentiation |
GO_1903351 | Biological process | cellular response to dopamine |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0072736 | Biological process | cellular response to tert-butyl hydroperoxide |
GO_1902455 | Biological process | negative regulation of stem cell population maintenance |
GO_0010971 | Biological process | positive regulation of G2/M transition of mitotic cell cycle |
GO_0030516 | Biological process | regulation of axon extension |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0001701 | Biological process | in utero embryonic development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006260 | Biological process | DNA replication |
GO_0051595 | Biological process | response to methylglyoxal |
GO_0031507 | Biological process | heterochromatin formation |
GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
GO_0060337 | Biological process | type I interferon-mediated signaling pathway |
GO_0010817 | Biological process | regulation of hormone levels |
GO_0042754 | Biological process | negative regulation of circadian rhythm |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0002218 | Biological process | activation of innate immune response |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_1900181 | Biological process | negative regulation of protein localization to nucleus |
GO_0008104 | Biological process | protein localization |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0021895 | Biological process | cerebral cortex neuron differentiation |
GO_0002230 | Biological process | positive regulation of defense response to virus by host |
GO_0048511 | Biological process | rhythmic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005730 | Cellular component | nucleolus |
GO_0000776 | Cellular component | kinetochore |
GO_0070822 | Cellular component | Sin3-type complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SIN3A |
Protein name | SIN3 transcription regulator family member A Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) |
Synonyms | |
Description | FUNCTION: Acts as a transcriptional repressor. Corepressor for REST. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Also interacts with MXD1-MAX heterodimers to repress transcription by tethering SIN3A to DNA. Acts cooperatively with OGT to repress transcription in parallel with histone deacetylation. Involved in the control of the circadian rhythms. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation. Cooperates with FOXK1 to regulate cell cycle progression probably by repressing cell cycle inhibitor genes expression (By similarity). Required for cortical neuron differentiation and callosal axon elongation (By similarity). . |
Accessions | ENST00000568431.5 ENST00000567289.5 A0A994J7C5 H3BQ88 A0A994J4B6 H3BMA2 A0A994J4B2 H3BT34 H3BQ76 ENST00000704312.1 ENST00000704302.1 ENST00000704311.1 ENST00000562776.5 ENST00000565264.2 ENST00000360439.8 H3BNZ3 ENST00000394949.8 H3BNA0 ENST00000394947.8 H3BP90 A0A994J7C7 ENST00000568309.5 Q96ST3 H3BQL7 ENST00000704310.1 ENST00000564778.6 ENST00000704304.1 ENST00000570115.5 ENST00000568190.1 ENST00000704305.1 |